Ohsawa, I
If your main issue is bloating without clear inflammation, KPV may not be the first tool to try
Wang RY, Weidner D, McQueen T, Andreeff M
The Selectivity Advantage The pivotal 1998 study by Raun and colleagues at Novo Nordisk characterized ipamorelin as "the first selective growth hormone secretagogue." The key finding was that even at doses far exceeding those required for GH release, ipamorelin did not produce meaningful elevations in ACTH, cortisol, prolactin, aldosterone, or thyroid-stimulating hormone
Sometimes there is genuine research there, he says, but its often taken to the extreme, dressed up with some science-y language, and claimed, This is efficacious. Id been experimenting with my own fitness long enough to understand that proof can be a big request